DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zeuzem S, Sarrazin C, Rouzier R. et al.
Anti-viral activity of SCH 503034, a HCV protease inhibitor, administered as monotherapy in hepatitis C genotype-1 (HCV-1) patients refractory to pegylated interferon (peg-IFN-α)
Hepatology 2005; 42: 233A-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.